ALPS Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,395
| Closed | -$275K | – | 1001 |
|
|
2024
Q4 | $275K | Hold |
7,395
| – | – | ﹤0.01% | 941 |
|
|
2024
Q3 | $359K | Sell |
7,395
-494
| -6% | -$24K | ﹤0.01% | 826 |
|
|
2024
Q2 | $316K | Sell |
7,889
-39
| -0.5% | -$1.56K | ﹤0.01% | 822 |
|
|
2024
Q1 | $348K | Buy |
7,928
+1,717
| +28% | +$75.4K | ﹤0.01% | 842 |
|
|
2023
Q4 | $384K | Sell |
6,211
-355
| -5% | -$22K | ﹤0.01% | 704 |
|
|
2023
Q3 | $302K | Sell |
6,566
-2,325
| -26% | -$107K | ﹤0.01% | 880 |
|
|
2023
Q2 | $511K | Buy |
8,891
+65
| +0.7% | +$3.74K | ﹤0.01% | 611 |
|
|
2023
Q1 | $331K | Sell |
8,826
-2,075
| -19% | -$77.8K | ﹤0.01% | 749 |
|
|
2022
Q4 | $305K | Sell |
10,901
-53
| -0.5% | -$1.49K | ﹤0.01% | 872 |
|
|
2022
Q3 | $308K | Buy |
+10,954
| New | +$308K | ﹤0.01% | 736 |
|
|
2017
Q3 | – | Sell |
-39,250
| Closed | -$701K | – | 780 |
|
|
2017
Q2 | $701K | Buy |
39,250
+101
| +0.3% | +$1.8K | ﹤0.01% | 293 |
|
|
2017
Q1 | $568K | Buy |
39,149
+15,820
| +68% | +$230K | ﹤0.01% | 307 |
|
|
2016
Q4 | $430K | Buy |
23,329
+221
| +1% | +$4.07K | ﹤0.01% | 535 |
|
|
2016
Q3 | $438K | Buy |
+23,108
| New | +$438K | ﹤0.01% | 370 |
|